Corporate Tech Investors

Santen Pharmaceuticals

Santen Pharmaceuticals is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Look, observe, and look closely. With our eyes we look at various objects. Our eyes are such essential organs, through which we obtain 80% of our information. Santen hopes to help many more people enjoy looking at various objects and scenes, particularly delightful scenes. As a specialized pharmaceutical company primarily engaged in the ophthalmic field, Santen has established a paramount position in Japan's prescription ophthalmic pharmaceutical market and has expanded into the global market.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/16/2015

Transaction History

Our records indicate that Santen Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Akira Kurokawa

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Santen Pharmaceuticals has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Santander InnoVentures | SAP National Security Serivces

Share this article

About Our Corporate VC Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary